My call is that with Dr Crombie at the helm VHL is about to be transformed and there is a strong possibility that the shares are going to increase 10 fold from 0.007c over the next two years. You just have to see what he has done since joining VHL. What will he do over the next few months? I do not think he is a man to stand still when there is genuine value to be created here for shareholders. He is incentivised with his incentive shares only vesting at stages up to 6c I think it is. MC of around $8m, cash of around $3.5m. 5 clinical trials as of H1 2015. The presentation he released to ASX today shows that similar companies with less clinical trials have valuations which could justify VHL being valued by the market at 10 times current valuation now.
There is a risk that they will do a capital raising, the price could be much higher or much lower. DYOR. High risk/high reward.
VHL Price at posting:
0.8¢ Sentiment: Buy Disclosure: Held
